C-RPQIRQKIEN
KPLQE,fromtheinternalregionofhumanZEB1.|Controlpeptidecorrespondingtopolyclonalantibody,Catalog#Z0469-75A,goatxhuman.||ZEB1inhibitsinterleukin-2(IL-2)geneexpression.Mayberespons
IBLefortranscriptionalrepressionoftheIL-2gene.EnhancesorrepressesthepromoteractivityoftheATP1A1genedependingonthequantityof
CDNAandonthecelltype.DefectsinZEB1arethecauseofposteriorpolymorphouscornealdystrophytype3(PPCD3)[MIM:609141].Posteriorpolymorphouscornealdystrophy(PPCD)isararediseaseinvolvingmetaplasiaandovergrowthofcornealendothelialcells.InpatientswithPPCD,thesecellsmanifestinanepithelialmorphologyandgeneexpressionpattern,produceanaberrantbasementmembrane,and,sometimes,spreadovertheirisandnearbystructuresinawaythatincreasestheriskforglaucoma.||Applications:|Suitableforusein
ELISA.Otherapplicationsnottested.||RecommendedDiltuinos:|Optimaldilutionstobedeterminedbytheresearcher.||StorageandSt
ABIlity:|Maybestoredat4°Cforshort-termonly.Forlong-termstorageandtoavoidrepeatedfreezingandthawing,aliquotandstoreat-20°C.Aliquotsarestableforatleast12monthsat-20°C.Formaximumrecoveryofproduct,centrifugetheoriginalvialafterthawingandpriortoremovingthecap.Furtherdilutionscanbemadeinassaybuffer.||PeptideBlocking(seecorrespondingantibodyZ0469-75A):|Antibodiesaretypicallysuppliedat0.5mg/mlandpeptidesasa100ulpellet.Whenpeptidesarereconstitutedin200ulwater,theconcentrationwouldbealso0.5mg/ml.Tostart,thebestratiowouldbe1:1(whichmeansmolarexcessofpeptidesrelativetoantibodieswhenidenticalvolumesaremixed).Mixequalvolumesofpeptideandantibodyattherequireddilutionandleaveatambienttemperature.Itisbestistohavetwoidenticalblots,tobeincubatedwithequalamountofantibodies,butonewiththeantibodiespre-adsorbedtothepeptidefor20min.Thenincubateanddevelopthetwoblotsinparallel.